PC
BIO icon

PointState Capital’s Bio-Rad Laboratories Class A BIO Stock Holding History

PointState Capital’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-4,500
Closed -$3.36M – 129
2021
Q3 		$3.36M Sell
4,500
-5,500
-55% -$4.12M 0.08% 111
2021
Q2 		$6.44M Buy
+10,000
New +$6.09M 0.15% 87
2018
Q3 		– Sell
-64,448
Closed -$18.6M – 145
2018
Q2 		$18.6M Hold
64,448
– – 0.22% 82
2018
Q1 		$16.1M Buy
64,448
+5,754
+10% +$1.47M 0.19% 80
2017
Q4 		$14M Sell
58,694
-9,906
-14% -$2.4M 0.15% 89
2017
Q3 		$15.2M Buy
+68,600
New +$15.4M 0.15% 94
2017
Q2 		– Sell
-20,100
Closed -$4.01M – 139
2017
Q1 		$4.01M Buy
+20,100
New +$3.87M 0.05% 114

Other funds holding BIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return